Orthobiologics Market size is predicted to rise from USD 8.46 billion to USD 17.04 billion, witnessing a CAGR of over 5.7% during the forecast timeline, from 2025 through 2037. In the year 2025, the industry size of orthobiologics is evaluated at USD 8.84 billion.
The market growth primarily be ascribed to rising cases of bone diseases across the globe. Based on the report provided by the National Library of Medicine (NLM), it was observed that around 1.5 million people suffer from fractures owing to some sort of bone disease every year.
Growing prevalence of low immunity and calcium deficiency owing to changing lifestyles and skyrocketing spending on medical technology are projected to influence the market revenue. As of 2019, the total revenue generated by medical technology was anticipated to be nearly USD 450 billion while the R&D spending on this technology was estimated to be around USD 30 billion in the same year. Orthobiologics is an injectable therapy that utilizes biological substances to heal musculoskeletal injuries rapidly. The substances used in the therapy are made from the materials naturally produced by the body.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
5.7% |
Base Year Market Size (2024) |
USD 8.46 billion |
Forecast Year Market Size (2037) |
USD 17.04 billion |
Regional Scope |
|
End-user (Clinics, Hospitals)
The hospitals segment in the orthobiologics market is projected to witness noteworthy growth over the forecast period. The growth of the segment can be accounted to the rising patient pool in hospitals worldwide. For instance, in 2019, approximately 7% of the US population was noticed to be hospitalized.
By Solutions |
|
By Application |
|
By End-User |
|
The North America region is expected to hold majority market share by the end of 2037. The growth of the market can be ascribed to rising geriatric population with severe bone diseases and the ongoing development in the healthcare expenditure of the region. As per the data published by the World Bank, it was noticed that the geriatric population in the United States reached 56,545,938 in 2021.
Author Credits: Radhika Pawar
Copyright © 2025 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?